Komori
Techno Medica (6678) · RiskRestated

Risk of supply suspension due to problems at contract manufacturers

First written in FY2016. 5 of 6 entries say "Restated". Latest entry: FY2024.

6entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20242016: 120162017: 120172018: 120182019: 120192020: 020202021: 020212022: 120222023: 020232024: 12024
Same theme, other companies
Risk of insufficient supply capacity and shutdowns at outsourced production partnersA theme 65 companies write about · 67 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2024: 10 of 32 companies on the "Worse" side.

34 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 65 companies compared. The sentences above are computed from all 65.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「Based on its long-standing business relationship with the company and the fact that the company has multiple cooperating suppliers, the company believes that stable product supplies through that company will be secured. However, if a serious problem arises at the contract manufacturer, the company may no longer be able to receive product supplies.」

    The company continues to disclose the possibility of supply disruption due to a serious problem at the contract manufacturer, while citing its long-term relationship with the contract manufacturer and other factors as the basis for supply stability.
  2. FY2022RestatedAnnual report

    「Based on its long-standing business relationship with the company and the fact that the company has multiple cooperating suppliers, the company believes that stable product supplies through that company will be secured. However, if a serious problem arises at the contract manufacturer, the company may no longer be able to receive product supplies.」

    The company continues to disclose the possibility of supply disruption due to a serious problem at the contract manufacturer, while citing its long-term relationship with the contract manufacturer and other factors as the basis for supply stability.
  3. FY2019RestatedAnnual report

    「Based on its long-standing business relationship with the company and the fact that the company has multiple cooperating suppliers, the company believes that stable product supplies through that company will be secured. However, if a serious problem arises at the contract manufacturer, the company may no longer be able to receive product supplies.」

    The company continues to disclose the possibility of supply disruption due to a serious problem at the contract manufacturer, while citing its long-term relationship with the contract manufacturer and other factors as the basis for supply stability.
  4. FY2018RestatedAnnual report

    「For the blood collection tube preparation device BC・ROBO-8001RFID, the company has entered into a basic agreement with 東芝産業機器システム株式会社, outsourced manufacturing to the company and adopted lot production.」

    The company explicitly states that manufacturing of BC・ROBO-8001RFID is outsourced to 東芝産業機器システム株式会社, while the risk of supply disruption due to a serious problem at the contract manufacturer remains.
  5. FY2017RestatedAnnual report

    「Based on its long-standing business relationship with the company and the fact that the company has multiple cooperating suppliers, the company believes that stable product supplies through that company will be secured. However, if a serious problem arises at the contract manufacturer, the company may no longer be able to receive product supplies.」

    The company continues to disclose the possibility of supply disruption due to a serious problem at the contract manufacturer, while citing its long-term business relationship and multiple cooperating suppliers as the basis for supply stability.
  6. FY2016First statedAnnual report

    「Based on its long-standing business relationship with the company and the fact that the company has multiple cooperating suppliers, the company believes that stable product supplies through that company will be secured. However, if a serious problem arises at the contract manufacturer, the company may no longer be able to receive product supplies.」

    The company cites its long-term business relationship and multiple cooperating suppliers as the basis for supply stability, while disclosing the possibility of supply disruption due to a serious problem at the contract manufacturer.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Techno Medica yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of supply suspension due to problems at contract manufacturers | Techno Medica Co.,Ltd. (6678) | Komori